Charlotte Girard

ORCID: 0009-0006-0467-9577
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Melanoma and MAPK Pathways
  • Cutaneous Melanoma Detection and Management
  • Pregnancy and preeclampsia studies
  • Cellular Mechanics and Interactions
  • Gestational Diabetes Research and Management
  • Neonatal Respiratory Health Research
  • Congenital Diaphragmatic Hernia Studies
  • Birth, Development, and Health
  • Cell Adhesion Molecules Research
  • Silk-based biomaterials and applications
  • Infant Development and Preterm Care

Inserm
2021-2025

Université Paris Cité
2025

Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
2025

Centre de Recherche Épidémiologie et Statistique
2025

Maternité Port Royal
2025

Assistance Publique – Hôpitaux de Paris
2025

Université Côte d'Azur
2021

La Ligue Contre le Cancer
2021

Abstract Objective Extremes of prepregnancy maternal BMI increase neonatal mortality and morbidity at term. They also the risk extremely preterm (EP, i.e., <27 weeks' gestational age) births. However, association between outcomes for EP babies is poorly understood. Methods We used a cross‐country design, bringing together following three population‐based, prospective, national birth cohorts: EXPRESS (Sweden, 2004–2007); EPICure 2 (UK, 2006); EPIPAGE (France, 2011). included all singleton...

10.1002/oby.24241 article EN cc-by Obesity 2025-02-06

Background Before 26 weeks of gestational age, because extremely preterm infants (EPI) face a high risk death or disability, management decisions may involve either active treatment palliative care. Survival chances largely depend on the willingness medical teams and parents to opt for management. Variability practices explains differences in survival between countries regions, interpersonal variability also exist among caregivers within same center. Our objective was study their...

10.1371/journal.pone.0320900 article EN cc-by PLoS ONE 2025-04-03

Abstract Lineage dedifferentiation towards a mesenchymal-like state is common mechanism of adaptive response and resistance to targeted therapy in melanoma. Yet, the transcriptional network driving this phenotypic plasticity remains elusive. Remarkably, cellular displays myofibroblast fibrotic features escapes MAPK inhibitors (MAPKi) through extracellular matrix (ECM) remodeling activities. Here we show that anti-fibrotic drug Nintedanib/BIBF1120 active normalize fibrous ECM network, enhance...

10.1101/2021.07.02.450838 preprint EN cc-by bioRxiv (Cold Spring Harbor Laboratory) 2021-07-03
Coming Soon ...